489 related articles for article (PubMed ID: 29133390)
1. Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib.
Kumari A; Ermilov AN; Grachtchouk M; Dlugosz AA; Allen BL; Bradley RM; Mistretta CM
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10369-E10378. PubMed ID: 29133390
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog pathway blockade with the cancer drug LDE225 disrupts taste organs and taste sensation.
Kumari A; Ermilov AN; Allen BL; Bradley RM; Dlugosz AA; Mistretta CM
J Neurophysiol; 2015 Feb; 113(3):1034-40. PubMed ID: 25392175
[TBL] [Abstract][Full Text] [Related]
3. Species generalization and differences in Hedgehog pathway regulation of fungiform and circumvallate papilla taste function and somatosensation demonstrated with sonidegib.
Kumari A; Yokota Y; Li L; Bradley RM; Mistretta CM
Sci Rep; 2018 Nov; 8(1):16150. PubMed ID: 30385780
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog Signaling Regulates Taste Organs and Oral Sensation: Distinctive Roles in the Epithelium, Stroma, and Innervation.
Mistretta CM; Kumari A
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884865
[TBL] [Abstract][Full Text] [Related]
5. Probing the multimodal fungiform papilla: complex peripheral nerve endings of chorda tympani taste and mechanosensitive fibers before and after Hedgehog pathway inhibition.
Donnelly CR; Kumari A; Li L; Vesela I; Bradley RM; Mistretta CM; Pierchala BA
Cell Tissue Res; 2022 Feb; 387(2):225-247. PubMed ID: 34859291
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling.
Ermilov AN; Kumari A; Li L; Joiner AM; Grachtchouk MA; Allen BL; Dlugosz AA; Mistretta CM
PLoS Genet; 2016 Nov; 12(11):e1006442. PubMed ID: 27893742
[TBL] [Abstract][Full Text] [Related]
7. Unique lingual expression of the Hedgehog pathway antagonist Hedgehog-interacting protein in filiform papillae during homeostasis and ectopic expression in fungiform papillae during Hedgehog signaling inhibition.
Kumari A; Li L; Ermilov AN; Franks NE; Dlugosz AA; Allen BL; Mistretta CM
Dev Dyn; 2022 Jul; 251(7):1175-1195. PubMed ID: 35048440
[TBL] [Abstract][Full Text] [Related]
8. Sonidegib for the treatment of advanced basal cell carcinoma.
Ramelyte E; Amann VC; Dummer R
Expert Opin Pharmacother; 2016 Oct; 17(14):1963-8. PubMed ID: 27538055
[TBL] [Abstract][Full Text] [Related]
9. Tongue and Taste Organ Biology and Function: Homeostasis Maintained by Hedgehog Signaling.
Mistretta CM; Kumari A
Annu Rev Physiol; 2017 Feb; 79():335-356. PubMed ID: 28192057
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog Pathway Inhibition.
Sekulic A; Von Hoff D
Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
[TBL] [Abstract][Full Text] [Related]
11. An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.
Danial C; Sarin KY; Oro AE; Chang AL
Clin Cancer Res; 2016 Mar; 22(6):1325-9. PubMed ID: 26546616
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Basset-Seguin N
Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS36-VS41. PubMed ID: 30477683
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
Danhof R; Lewis K; Brown M
Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
[TBL] [Abstract][Full Text] [Related]
14. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
15. Anterior and Posterior Tongue Regions and Taste Papillae: Distinct Roles and Regulatory Mechanisms with an Emphasis on Hedgehog Signaling and Antagonism.
Kumari A; Mistretta CM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902260
[TBL] [Abstract][Full Text] [Related]
16. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.
Chen L; Silapunt S; Migden MR
Future Oncol; 2016 Sep; 12(18):2095-105. PubMed ID: 27189494
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.
Skvara H; Kalthoff F; Meingassner JG; Wolff-Winiski B; Aschauer H; Kelleher JF; Wu X; Pan S; Mickel L; Schuster C; Stary G; Jalili A; David OJ; Emotte C; Antunes AM; Rose K; Decker J; Carlson I; Gardner H; Stuetz A; Bertolino AP; Stingl G; De Rie MA
J Invest Dermatol; 2011 Aug; 131(8):1735-44. PubMed ID: 21430703
[TBL] [Abstract][Full Text] [Related]
18. Sonidegib phosphate: new approval for basal cell carcinoma.
Tibes R
Drugs Today (Barc); 2016 May; 52(5):295-303. PubMed ID: 27376162
[TBL] [Abstract][Full Text] [Related]
19. Regeneration of fungiform taste buds: temporal and spatial characteristics.
Cheal M; Oakley B
J Comp Neurol; 1977 Apr; 172(4):609-26. PubMed ID: 838892
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma.
Collier NJ; Ali FR; Lear JT
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1011-8. PubMed ID: 27636236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
